Measurement of utility values in the UK for health states related to immune thrombocytopenic purpura.
about
Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in IrelandHealth-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries.Descriptions of health states associated with increasing severity and frequency of hypoglycemia: a patient-level perspective.Economic evaluation of arsenic trioxide compared to all-trans retinoic acid + conventional chemotherapy for treatment of relapsed acute promyelocytic leukemia in Canada.
P2860
Measurement of utility values in the UK for health states related to immune thrombocytopenic purpura.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Measurement of utility values ...... mune thrombocytopenic purpura.
@ast
Measurement of utility values ...... mune thrombocytopenic purpura.
@en
type
label
Measurement of utility values ...... mune thrombocytopenic purpura.
@ast
Measurement of utility values ...... mune thrombocytopenic purpura.
@en
prefLabel
Measurement of utility values ...... mune thrombocytopenic purpura.
@ast
Measurement of utility values ...... mune thrombocytopenic purpura.
@en
P2093
P1476
Measurement of utility values ...... mune thrombocytopenic purpura.
@en
P2093
Agota Szende
Caroline Schaefer
John Brazier
John J Isitt
Robert Deuson
P304
P356
10.1185/03007995.2010.494126
P407
P50
P577
2010-08-01T00:00:00Z